Targeting epigenetic regulators, such as histone-modifying enzymes, provides novel strategies for cancer therapy. The GCN5 lysine acetyltransferase (KAT) functions together with MYC both during normal development and in oncogenesis. As transcription factors, MYC family members are difficult to target with small-molecule inhibitors, but the acetyltransferase domain and the bromodomain in GCN5 might provide alternative targets for disruption of MYC-driven functions. GCN5 is part of two distinct multiprotein histone-modifying complexes, SAGA and ATAC. This review summarizes key findings on the roles of SAGA and ATAC in embryo development and in cancer to better understand the functional relationships of these complexes with MYC family members, as well as their future potential as therapeutic targets.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231639 | PMC |
| http://dx.doi.org/10.1158/0008-5472.CAN-19-3652 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
ATAC and SAGA histone acetyltransferase modules facilitate transcription factor binding to nucleosomes independent of their acetylation activity.
Nucleic Acids Res
January 2025
Ohio State Biochemistry Program, Ohio State University, 191 W. Woodruff Ave. Columbus, OH, 43210, USA.
Transcription initiation involves the coordination of multiple events, starting with activators binding specific DNA target sequences, which recruit transcription coactivators to open chromatin and enable binding of general transcription factors and RNA polymerase II to promoters. Two key human transcriptional coactivator complexes, ATAC (ADA-two-A-containing) and SAGA (Spt-Ada-Gcn5 acetyltransferase), containing histone acetyltransferase (HAT) activity, target genomic loci to increase promoter accessibility. To better understand the function of ATAC and SAGA HAT complexes, we used in vitro biochemical and biophysical assays to characterize human ATAC and SAGA HAT module interactions with nucleosomes and how a transcription factor (TF) coordinates these interactions.
View Article and Find Full Text PDFKAT tales: Functions of Gcn5 and PCAF lysine acetyltransferases in SAGA and ATAC.
J Biol Chem
October 2024
Department of Epigenetics and Molecular Carcinogenesis, University of Texas M.D. Anderson Cancer, Center for Cancer Epigenetics, University of Texas M.D. Anderson/UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas, USA. Electronic address:
The Allis group identified Gcn5 as the first transcription-related lysine acetyltransferase in 1996, providing a molecular "missing link" between chromatin organization and gene regulation. This review will focus on functions subsequently identified for Gcn5 and the closely related PCAF protein, in the context of two major complexes, SAGA and ATAC, and how the study of these enzymes informs long standing questions regarding the importance of lysine acetylation.
View Article and Find Full Text PDFThe SAGA acetyltransferase module is required for the maintenance of MAF and MYC oncogenic gene expression programs in multiple myeloma.
Genes Dev
September 2024
Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA;
Article Synopsis
- - Despite advancements in treatment, multiple myeloma (MM) is still an incurable cancer, with gaps in understanding the epigenetic mechanisms that contribute to its development and progression.
- - The study focuses on the SAGA complex, particularly the ADA2B subunit, which plays a critical role in regulating key pathways like MTORC1 signaling and oncogenic programs associated with transcription factors MYC, E2F, and MAF.
- - The research reveals that targeting SAGA's KAT module and its interaction with specific acetyltransferases could present new therapeutic vulnerabilities in MM, potentially leading to future treatment strategies.
The SAGA acetyltransferase module is required for the maintenance of MAF and MYC oncogenic gene expression programs in multiple myeloma.
bioRxiv
April 2024
Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Despite recent advances in therapeutic treatments, multiple myeloma (MM) remains an incurable malignancy. Epigenetic factors contribute to the initiation, progression, relapse, and clonal heterogeneity in MM, but our knowledge on epigenetic mechanisms underlying MM development is far from complete. The SAGA complex serves as a coactivator in transcription and catalyzes acetylation and deubiquitylation.
View Article and Find Full Text PDFTherapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug Discovery.
Sci Adv
February 2024
Department of Systems Biology, Beckman Research Institute, City of Hope, Duarte, CA, USA.
Article Synopsis
- Epigenetic dysregulation is linked to various cancers, particularly leukemias, and the study explores the role of Tudor domains in leukemia progression and treatment.
- Researchers used a CRISPR screen to find SGF29, a vital part of acetyltransferase complexes, which is important for gene expression and the development of leukemia.
- The study introduced a new strategy called CRISPR-SADD for drug discovery, helping to identify a promising inhibitor that targets SGF29's Tudor domain and shows effectiveness against leukemia, suggesting broad applicability for future drug development.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!